Changes of Immunological Profiles in Patients with Chronic Myeloid Leukemia in the Course of Treatment

Table 7

Presence and geometric mean titres of antibodies against human herpesviruses in CML patients prior to the start of the therapy and after achieiving hematological and/or complete cytogenetic remission.

antibody presence
Sample	No.	HSV1/2		CMV		VZV		EBV
		IgG	IgM	IgG	IgM	IgG	IgM	VCAIgG	VCAIgM	EAIgG	EBNA IgM
First	11	11	2	8	0	11	2	11	2	3	10
Last	11	11	0	8	1	11	2	11	2	3	10
GMT
First	11	8.12	0.65	1.83	0.47	2.83	0.74	7.41	0.33	0.57	4.28
Last	11	8.33	0.57	2.01	0.47	2.61	0.54	8.20	0.34	0.65	4.79